Putnam Investments LLC Rapt Therapeutics, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 27,027 shares of RAPT stock, worth $23,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,027
Previous 20,097
34.48%
Holding current value
$23,783
Previous $334,000
100.9%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RAPT
# of Institutions
101Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$19.7 Million7.04% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$11.6 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$11.6 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$11 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$10.4 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $26.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...